drugset / Trial / NCT01980849
Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer
RandomizedParallel-groupOpen-labelPrevention
Summary
To compare the efficacy and safety of prophylaxis of venous thromboembolism by Nadroparin during hospitalization to long-term usage in patients with advanced lung cancer treated by chemotherapy and/or radiotherapy.
Timeline
- Start
- 2013-11
- Primary completion
- 2016-11
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nadroparin Calcium | Other / unclassified | 0.4 ml | Subcutaneous |